Venture Capital

Rain Therapeutics Aims For $125 Million U.S. IPO (RAIN)


Rain Therapeutics has filed to raise $125 million in an IPO of its common stock. The firm is developing treatments for solid tumor cancers.

Read more

Show More

Related Articles

Back to top button